日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Landscape of T-cell engagers in solid tumors

实体瘤中T细胞衔接器的研究概况

Garcia-Lorenzo, Esther; Dorta, Miriam; Doger, Bernard; Pedregal, Manuel; Moreno, Victor

Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study

帕利他米(Pasritamig)是一种首创的双特异性T细胞衔接剂,靶向人激肽释放酶2,用于治疗转移性去势抵抗性前列腺癌:一项I期研究

Stein, Mark N; Vinceneux, Armelle; Robbrecht, Debbie; Doger, Bernard; Autio, Karen A; Schweizer, Michael T; Calvo, Emiliano; Medina, Laura; Van Dongen, Marloes; Deville, Jean-Laurent; Bernard-Tessier, Alice; Ghosh, Debopriya; Shotts, Kristin; Shen, Fei; Jaiprasart, Pharavee; Chaudhary, Ruchi; Wu, Shujian; Cartee, Leanne; Schnepp, Robert; Gaut, Daria; Lauring, Josh; Wang, Sherry C; Villalobos, Victor M; Baldini, Capucine

First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation

Zelenecide Pevedotin治疗晚期实体瘤患者的首次人体I/II期剂量递增和扩展研究:单药治疗剂量递增的结果

Baldini, Capucine; Verlingue, Loic; Goldschmidt, Vincent; Doger de Spéville, Bernard; Lostes, Julia; Italiano, Antoine; Cousin, Sophie; Falchook, Gerald S; Necchi, Andrea; Reig Torras, Oscar; Fontana, Elisa; Carter, Louise; Rodon Ahnert, Jordi; Brown, Jason R; DeMars, Leslie R; Josephs, Kate; Dickson, Amy; Xu, Cong; Bader, Justin; Campbell, Carly; Sharma, Rajiv; McKean, Meredith

BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter study

BOS172738 是一种选择性 RET 抑制剂,用于治疗 RET 改变的肿瘤患者,包括 RET 融合阳性非小细胞肺癌和 RET 突变型甲状腺髓样癌:一项 I 期剂量递增/扩展多中心研究

Schöffski, P; Gazzah, A; Trigo, J; Italiano, A; Gougis, P; Subbiah, V; Shih, J-Y; Loong, H H; Doger, B; Keegan, M; Jeglinski, B; Andreas, K; Cho, B C

Prolonged survival in a patient with pbrm1 mutated metastatic cholangiocarcinoma receiving tazemetostat

接受tazemetostat治疗的pbrm1突变转移性胆管癌患者生存期延长。

Pedregal, Manuel; Morafraile, Esther Cabañas; Garrido, Alberto; Doger, Bernard; Hernandez, Tatiana; Morillo, Daniel; Győrffy, Balázs; Ocaña, Alberto; Minguez, Pablo; Moreno, Victor

A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer

JNJ-70218902(一种针对TMEFF2的双特异性T细胞重定向抗体)在转移性去势抵抗性前列腺癌中的首次人体研究

Calvo, Emiliano; Doger, Bernard; Carles, Joan; Peer, Avivit; Sarid, David; Eigl, Bernhard J; Avadhani, Anjali; Yao, David; Lin, Vincent; Wu, Shujian; Jaiprasart, Pharavee; Loffredo, John; Tamegnon, Monelle; Xu, Weichun; Xie, Hong; Hansen, Aaron R

In silico evaluation of the immunogenic profile of lung cancers with SMARCA4 genetic alterations

利用计算机模拟评估SMARCA4基因改变肺癌的免疫原性特征

Nieto-Jiménez, Cristina; Garcia-Lorenzo, Esther; Diaz-Tejeiro, Cristina; Paniagua-Herranz, Lucía; Sanvicente, Adrián; Doger, Bernard; Moreno, Irene; Pedregal, Manuel; Bartolomé, Jorge; Manzano, Arancha; Munkácsy, Gyöngyi; Győrffy, Balázs; Pérez-Segura, Pedro; Calvo, Emiliano; Moreno, Victor; Ocana, Alberto

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors

新型抗CD25 Treg细胞清除剂RG6292单药及联合阿特珠单抗治疗实体瘤患者的安全性和抗肿瘤活性

Gambardella, Valentina; Ong, Michael; Rodriguez-Ruiz, Maria E; Machiels, Jean-Pascal; Sanmamed, Miguel F; Galvao, Vladimir; Spreafico, Anna; Renouf, Daniel J; Luen, Stephen J; Galot, Rachel; Doger de Spéville, Bernard; Calvo, Emiliano; Naing, Aung; Curdt, Samira; Kolben, Theresa Maria; Rossmann, Eva; Tanos, Tamara; Smart, Kevin; Amann, Maria; Xie, Yuying; Xu, Linxinyu; Gomez Alcaide, Enrique; Städler, Nicolas; Justies, Nicole; Boetsch, Christophe; Karanikas, Vaios; Schnetzler, Gabriel; Rohrberg, Kristoffer S

Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers

Beamion BCGC-1:zongertinib治疗晚期HER2阳性乳腺癌或胃食管癌的Ib/II期试验

Hurvitz, Sara; Simonelli, Matteo; Yarza, Ramón; Berz, David; Kitano, Shigehisa; Del Conte, Gianluca; Acosta Eyzaguirre, Daniel; Doger de Speville Uribe, Bernard Gaston; Maier, Daniela; Erzen, Damijan; Aykut Yazgili, Sila; Curigliano, Giuseppe; Deng, Ting; Yan, Min; Zhang, Qingyuan; Wang, Xian; Nakayama, Izuma; Shitara, Kohei

MYC targeting by OMO-103 in solid tumors: a phase 1 trial

OMO-103靶向MYC治疗实体瘤:一项I期试验

Garralda, Elena; Beaulieu, Marie-Eve; Moreno, Víctor; Casacuberta-Serra, Sílvia; Martínez-Martín, Sandra; Foradada, Laia; Alonso, Guzman; Massó-Vallés, Daniel; López-Estévez, Sergio; Jauset, Toni; Corral de la Fuente, Elena; Doger, Bernard; Hernández, Tatiana; Perez-Lopez, Raquel; Arqués, Oriol; Castillo Cano, Virginia; Morales, Josefa; Whitfield, Jonathan R; Niewel, Manuela; Soucek, Laura; Calvo, Emiliano